A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors

Inclusion criteria: * Patients with histologically confirmed solid tumors or non-Hodgkin's lymphoma with progression on prior standard therapies. * Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2 * Adequate kidney function and laboratory values Exclusion criteria: * Patients who have received chemotherapy, any investigational drug, undergone major surgery, or received wide field radiotherapy less than 4 weeks ago * Patients who had a heart attack or have unstable angina within past 6 months * Heart disease including congestive heart failure and uncontrolled high blood pressure * Liver disease, abnormal gastrointestinal (GI) function or ongoing diarrhea * Use of any anti-cancer therapy, including radiation therapy, or certain drugs while on study * Female patients who are pregnant or breast feeding. Other protocol inclusion/exclusion criteria may apply.